Lilly launches Mounjaro in India for treatment of obesity and type 2 diabetes
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The company has received five final approvals
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated